Effects of m6A RNA methylation regulators on endometrial cancer

被引：28

作者：

Zhang, Yanli ^{[1
]}

Yang, Yingjie ^{[2
]}

机构：

[1] Soochow Univ, Med Coll, Dept Obstet & Gynecol, Suzhou, Peoples R China

[2] Guizhou Med Univ, Affiliated Canc Hosp, Dept Gynecol Surg, Guiyang, Peoples R China

来源：

JOURNAL OF CLINICAL LABORATORY ANALYSIS | 2021年 / 35卷 / 09期

关键词：

bioinformatic analysis; endometrial cancer; methylation; FTO GENE; M(6)A; PROGRESSION; STATISTICS; OBESITY; YTHDF1; RISK; MASS;

D O I：

10.1002/jcla.23942

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

Background The modification 6-methyladenine (m(6)A) is the most common type in RNA methylation. Our study aims to explore the bioinformatic analysis of m(6)A in endometrial cancer. Methods The expression of 23 m(6)A RNA methylation regulators was compared through The Cancer Genome Atlas (TCGA) database among 406 endometrial tissue and 19 normal tissue samples. The Wilcoxon test was applied to compare the relationship between the clinicopathological characteristics and expression. Cox regressions were performed to identify the prognostic factors associated with overall survival. Gene ontology (GO) and Gene Set Enrichment Analysis (GSEA) were performed to evaluate the potential pathways. Results YTHDF2, HNRNPA2B1, HDRNPA2B1, YTHDF1, FMR1, IGF2BP3, METTL13, RBM15B, IGF2BP1, YTHDF3, YTHDC1, ZC3H13 IGF2BP2, KIAA1429, METTL14, RBMX, FTO, ALKBH5, and METTL16 were significantly abnormally expressed in endometrial cancer tissue samples. Both univariate and multivariate Cox regression analyses indicated that age, grade, and risk score were independent risk factors. High expression of FTO was associated with worse overall survival. Conclusion M(6)A RNA methylation regulators play vital role in endometrial cancer.

引用

页数：8

共 32 条

[1] MODOMICS: a database of RNA modification pathways. 2017 update [J].

Boccaletto, Pietro ;

Machnicka, Magdalena A. ;

Purta, Elzbieta ;

Piatkowski, Pawe ;

Baginski, Blazej ;

Wirecki, Tomasz K. ;

de Crecy-Lagard, Valerie ;

Ross, Robert ;

Limbach, Patrick A. ;

Kotter, Annika ;

Helm, Mark ;

Bujnicki, Janusz M. .

NUCLEIC ACIDS RESEARCH, 2018, 46 (D1) :D303-D307

[2] Current recommendations and recent progress in endometrial cancer [J].

Brooks, Rebecca A. ;

Fleming, Gini F. ;

Lastra, Ricardo R. ;

Lee, Nita K. ;

Moroney, John W. ;

Son, Christina H. ;

Tatebe, Ken ;

Veneris, Jennifer L. .

CA-A CANCER JOURNAL FOR CLINICIANS, 2019, 69 (04) :258-279

[3] Novel positioning from obesity to cancer: FTO, an m6A RNA demethylase, regulates tumour progression [J].

Chen, JiaLing ;

Du, Bin .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (01) :19-29

[4] RBMX family proteins, connect the fields of nuclear RNA processing, disease and sex chromosome biology [J].

Elliott, David J. ;

Dalgliesh, Caroline ;

Hysenaj, Gerald ;

Ehrmann, Ingrid .

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2019, 108 :1-6

[5] Inactivation of the Fto gene protects from obesity [J].

Fischer, Julia ;

Koch, Linda ;

Emmerling, Christian ;

Vierkotten, Jeanette ;

Peters, Thomas ;

Bruening, Jens C. ;

Ruether, Ulrich .

NATURE, 2009, 458 (7240) :894-U10

[6] A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity [J].

Frayling, Timothy M. ;

Timpson, Nicholas J. ;

Weedon, Michael N. ;

Zeggini, Eleftheria ;

Freathy, Rachel M. ;

Lindgren, Cecilia M. ;

Perry, John R. B. ;

Elliott, Katherine S. ;

Lango, Hana ;

Rayner, Nigel W. ;

Shields, Beverley ;

Harries, Lorna W. ;

Barrett, Jeffrey C. ;

Ellard, Sian ;

Groves, Christopher J. ;

Knight, Bridget ;

Patch, Ann-Marie ;

Ness, Andrew R. ;

Ebrahim, Shah ;

Lawlor, Debbie A. ;

Ring, Susan M. ;

Ben-Shlomo, Yoav ;

Jarvelin, Marjo-Riitta ;

Sovio, Ulla ;

Bennett, Amanda J. ;

Melzer, David ;

Ferrucci, Luigi ;

Loos, Ruth J. F. ;

Barroso, Ines ;

Wareham, Nicholas J. ;

Karpe, Fredrik ;

Owen, Katharine R. ;

Cardon, Lon R. ;

Walker, Mark ;

Hitman, Graham A. ;

Palmer, Colin N. A. ;

Doney, Alex S. F. ;

Morris, Andrew D. ;

Smith, George Davey ;

Hattersley, Andrew T. ;

McCarthy, Mark I. .

SCIENCE, 2007, 316 (5826) :889-894

[7] FTO-mediated formation of N6-hydroxymethyladenosine and N6-formyladenosine in mammalian RNA [J].

Fu, Ye ;

Jia, Guifang ;

Pang, Xueqin ;

Wang, Richard N. ;

Wang, Xiao ;

Li, Charles J. ;

Smemo, Scott ;

Dai, Qing ;

Bailey, Kathleen A. ;

Nobrega, Marcelo A. ;

Han, Ke-Li ;

Cui, Qiang ;

He, Chuan .

NATURE COMMUNICATIONS, 2013, 4

[8] Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells [J].

Han, Dali ;

Liu, Jun ;

Chen, Chuanyuan ;

Dong, Lihui ;

Liu, Yi ;

Chang, Renbao ;

Huang, Xiaona ;

Liu, Yuanyuan ;

Wang, Jianying ;

Dougherty, Urszula ;

Bissonnette, Marc B. ;

Shen, Bin ;

Weichselbaum, Ralph R. ;

Xu, Meng Michelle ;

He, Chuan .

NATURE, 2019, 566 (7743) :270-+

[9] Association between FTO gene polymorphism (rs9939609 T/A) and cancer risk: a meta-analysis [J].

Huang, Xiaoyi ;

Zhao, Jian ;

Yang, Mingyuan ;

Li, Ming ;

Zheng, Jianming .

EUROPEAN JOURNAL OF CANCER CARE, 2017, 26 (05)

[10]

Kaaks R, 2002, CANCER EPIDEM BIOMAR, V11, P1531

← 1 2 3 4 →